-
1
-
-
0027939487
-
Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes
-
Fletcher JA, Gebhardt MC, Kozakewich HP,. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes. Cancer Genet Cytogenet 1994; 77: 81-8.
-
(1994)
Cancer Genet Cytogenet
, vol.77
, pp. 81-88
-
-
Fletcher, J.A.1
Gebhardt, M.C.2
Kozakewich, H.P.3
-
2
-
-
1942530423
-
Conventional osteosarcoma
-
Fletcher C.D.M. Unni K.K. Mertens F. eds. Lyon: IARC Press
-
Raymond AK, Ayala AG, Knuutila S., Conventional osteosarcoma. In:, Fletcher CDM, Unni KK, Mertens F, eds. World health classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002. 264-70.
-
(2002)
World Health Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
, pp. 264-270
-
-
Raymond, A.K.1
Ayala, A.G.2
Knuutila, S.3
-
3
-
-
0141799898
-
Mechanisms of sarcoma development
-
Helman LJ, Meltzer P,. Mechanisms of sarcoma development. Nat Rev Cancer 2003; 3: 685-94.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 685-694
-
-
Helman, L.J.1
Meltzer, P.2
-
4
-
-
68949192290
-
Prognostic factors and outcomes for osteosarcoma: An international collaboration
-
Pakos EE, Nearchou AD, Grimer RJ, et al. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer 2009; 45: 2367-75.
-
(2009)
Eur J Cancer
, vol.45
, pp. 2367-2375
-
-
Pakos, E.E.1
Nearchou, A.D.2
Grimer, R.J.3
-
5
-
-
33846981552
-
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup
-
Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112-28.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 112-128
-
-
Lewis, I.J.1
Nooij, M.A.2
Whelan, J.3
-
6
-
-
33646889372
-
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
-
Eselgrim M, Grunert H, Kuhne T, et al. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatr Blood Cancer 2006; 47: 42-50.
-
(2006)
Pediatr Blood Cancer
, vol.47
, pp. 42-50
-
-
Eselgrim, M.1
Grunert, H.2
Kuhne, T.3
-
7
-
-
80054914908
-
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
-
Anninga JK, Gelderblom H, Fiocco M, et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur J Cancer 2011; 47: 2431-45.
-
(2011)
Eur J Cancer
, vol.47
, pp. 2431-2445
-
-
Anninga, J.K.1
Gelderblom, H.2
Fiocco, M.3
-
8
-
-
84862776906
-
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
-
Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506-10.
-
(2012)
Nature
, vol.481
, pp. 506-510
-
-
Ding, L.1
Ley, T.J.2
Larson, D.E.3
-
9
-
-
84859722355
-
Bone: Conventional osteosarcoma
-
Mohseny AB,. Bone: conventional osteosarcoma. Atlas Genet Cytogenet Oncol Haematol 2008. (http://atlasgeneticsoncology.org/Tumors/ConvOsteoID5344.html).
-
(2008)
Atlas Genet Cytogenet Oncol Haematol
-
-
Mohseny, A.B.1
-
10
-
-
0036275220
-
Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup
-
Hauben EI, Weeden S, Pringle J,et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002; 38: 1218-25.
-
(2002)
Eur J Cancer
, vol.38
, pp. 1218-1225
-
-
Hauben, E.I.1
Weeden, S.2
Pringle, J.3
-
11
-
-
32444446700
-
Clinico-histologic parameters of osteosarcoma patients with late relapse
-
Hauben EI, Bielack S, Grimer R, et al. Clinico-histologic parameters of osteosarcoma patients with late relapse. Eur J Cancer 2006; 42: 460-6.
-
(2006)
Eur J Cancer
, vol.42
, pp. 460-466
-
-
Hauben, E.I.1
Bielack, S.2
Grimer, R.3
-
12
-
-
79953000341
-
Concise review: Mesenchymal tumors: When stem cells go mad
-
Mohseny AB, Hogendoorn PCW,. Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 2011; 29: 397-403.
-
(2011)
Stem Cells
, vol.29
, pp. 397-403
-
-
Mohseny, A.B.1
Hogendoorn, P.C.W.2
-
13
-
-
10844296836
-
Skeletogenesis: Genetics
-
Cooper D.N. ed. London: Nature Publishing Group
-
Hogendoom PCW, Bovee JVMG, Karperien M, et al. Skeletogenesis: genetics. In:, Cooper DN, ed. Nature encyclopedia of the human genome. London: Nature Publishing Group, 2003. 306-13.
-
(2003)
Nature Encyclopedia of the Human Genome
, pp. 306-313
-
-
Hogendoom, P.C.W.1
Bovee, J.2
Karperien, M.3
-
14
-
-
33846910469
-
Sarcoma derived from cultured mesenchymal stem cells
-
Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-9.
-
(2007)
Stem Cells
, vol.25
, pp. 371-379
-
-
Tolar, J.1
Nauta, A.J.2
Osborn, M.J.3
-
15
-
-
70350457821
-
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2
-
Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009; 219: 294-305.
-
(2009)
J Pathol
, vol.219
, pp. 294-305
-
-
Mohseny, A.B.1
Szuhai, K.2
Romeo, S.3
-
16
-
-
84860681385
-
An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration
-
Mohseny AB, Xiao W, Carvalho R, et al. An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration. J Pathol 2012; 227: 245-53.
-
(2012)
J Pathol
, vol.227
, pp. 245-253
-
-
Mohseny, A.B.1
Xiao, W.2
Carvalho, R.3
-
19
-
-
34248582829
-
Cancer cell lines as genetic models of their parent histology: Analyses based on array comparative genomic hybridization
-
Greshock J, Nathanson K, Martin AM, et al. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res 2007; 67: 3594-600.
-
(2007)
Cancer Res
, vol.67
, pp. 3594-3600
-
-
Greshock, J.1
Nathanson, K.2
Martin, A.M.3
-
20
-
-
74949090294
-
Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet Effort
-
Ottaviano L, Schaefer KL, Gajewski M, et al. Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet Effort. Genes Chromosomes Cancer 2010; 49: 40-51.
-
(2010)
Genes Chromosomes Cancer
, vol.49
, pp. 40-51
-
-
Ottaviano, L.1
Schaefer, K.L.2
Gajewski, M.3
-
21
-
-
27644509946
-
Central high-grade osteosarcoma of bone: Diagnostic and genetic considerations
-
Cleton-Jansen AM, Buerger H, Hogendoom PCW,. Central high-grade osteosarcoma of bone: diagnostic and genetic considerations. Curr Diagn Pathol 2005; 11: 390-9.
-
(2005)
Curr Diagn Pathol
, vol.11
, pp. 390-399
-
-
Cleton-Jansen, A.M.1
Buerger, H.2
Hogendoom, P.C.W.3
-
22
-
-
0141705379
-
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
-
Overholtzer M, Rao PH, Favis R, et al. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA 2003; 100: 11547-52.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 11547-11552
-
-
Overholtzer, M.1
Rao, P.H.2
Favis, R.3
-
23
-
-
79960909993
-
Functional characterization of osteosarcoma cell lines provides representative models to study the human disease
-
Mohseny AB, Machado I, Cai Y, et al. Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Lab Invest 2011; 91: 1195-205.
-
(2011)
Lab Invest
, vol.91
, pp. 1195-1205
-
-
Mohseny, A.B.1
Machado, I.2
Cai, Y.3
-
24
-
-
77957554389
-
A tissue microarray study of osteosarcoma: Histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models
-
Mayordomo E, Machado I, Giner F, et al. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol 2010; 18: 453-61.
-
(2010)
Appl Immunohistochem Mol Morphol
, vol.18
, pp. 453-461
-
-
Mayordomo, E.1
Machado, I.2
Giner, F.3
-
25
-
-
84855482786
-
Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
-
Kresse SH, Meza-Zepeda LA, Machado I, et al. Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations. Cancer 2012; 118: 558-70.
-
(2012)
Cancer
, vol.118
, pp. 558-570
-
-
Kresse, S.H.1
Meza-Zepeda, L.A.2
Machado, I.3
-
26
-
-
0024359778
-
C-fos Expression induces bone tumors in transgenic mice
-
Ruther U, Komitowski D, Schubert FR, et al. c-fos Expression induces bone tumors in transgenic mice. Oncogene 1989; 4: 861-5.
-
(1989)
Oncogene
, vol.4
, pp. 861-865
-
-
Ruther, U.1
Komitowski, D.2
Schubert, F.R.3
-
27
-
-
45349086509
-
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
-
Walkley CR, Qudsi R, Sankaran VG, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22: 1662-76.
-
(2008)
Genes Dev
, vol.22
, pp. 1662-1676
-
-
Walkley, C.R.1
Qudsi, R.2
Sankaran, V.G.3
-
28
-
-
80053173117
-
MRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
-
Kuijjer ML, Namløs HM, Hauben EI, et al. mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. BMC Research Notes 2011; 4: 66.
-
(2011)
BMC Research Notes
, vol.4
, pp. 66
-
-
Kuijjer, M.L.1
Namløs, H.M.2
Hauben, E.I.3
-
29
-
-
84855482786
-
Preclinical xenograft models of human sarcoma show non-random loss of aberrations
-
Kresse SH, Meza-Zepeda LA, Machado I, et al. Preclinical xenograft models of human sarcoma show non-random loss of aberrations. Cancer 2012; 118: 558-70.
-
(2012)
Cancer
, vol.118
, pp. 558-570
-
-
Kresse, S.H.1
Meza-Zepeda, L.A.2
Machado, I.3
-
30
-
-
79959503826
-
The International HapMap Project
-
The International HapMap Project. Nature 2003; 426: 789-96.
-
(2003)
Nature
, vol.426
, pp. 789-796
-
-
-
31
-
-
79954573473
-
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: A rationale for treatment with macrophage- activating agents
-
Buddingh EP, Kuijjer ML, Duim RA, et al. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents. Clin Cancer Res 2011; 17: 2110-9.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2110-2119
-
-
Buddingh, E.P.1
Kuijjer, M.L.2
Duim, R.A.3
-
32
-
-
80052703371
-
Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma
-
Su Y, Wagner ER, Luo Q, et al. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 2011; 30: 3907-17.
-
(2011)
Oncogene
, vol.30
, pp. 3907-3917
-
-
Su, Y.1
Wagner, E.R.2
Luo, Q.3
-
33
-
-
70649090109
-
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
-
Cleton-Jansen AM, Anninga JK, Briaire-de Bruijn I, et al. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 2009; 101: 2064.
-
(2009)
Br J Cancer
, vol.101
, pp. 2064
-
-
Cleton-Jansen, A.M.1
Anninga, J.K.2
Briaire-De Bruijn, I.3
-
34
-
-
84858116745
-
Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
-
Namløs HM, Kresse SH, Muller CR, et al. Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. Sarcoma 2012; 2012: 639038.
-
(2012)
Sarcoma
, vol.2012
, pp. 639038
-
-
Namløs, H.M.1
Kresse, S.H.2
Muller, C.R.3
-
35
-
-
0031943038
-
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: Study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin
-
Bacci G, Ferrari S, Delepine N, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol 1998; 16: 658-63.
-
(1998)
J Clin Oncol
, vol.16
, pp. 658-663
-
-
Bacci, G.1
Ferrari, S.2
Delepine, N.3
-
37
-
-
33644505791
-
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution
-
Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy-15-year experience in 789 patients treated at a single institution. Cancer 2006; 106: 1154-61.
-
(2006)
Cancer
, vol.106
, pp. 1154-1161
-
-
Bacci, G.1
Longhi, A.2
Versari, M.3
-
38
-
-
33846978784
-
Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
-
Dupuy A, Simon RM,. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 2007; 99: 147-57.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 147-157
-
-
Dupuy, A.1
Simon, R.M.2
-
39
-
-
70350453743
-
Relative power and sample size analysis on gene expression profiling data
-
van Iterson M, 't Hoen, PA, Pedotti, P, et al. Relative power and sample size analysis on gene expression profiling data. BMC Research Notes 2009; 10: 439.
-
(2009)
BMC Research Notes
, vol.10
, pp. 439
-
-
Hoen Van Iterson M, '.T.1
Pedotti, P.A.P.2
-
40
-
-
78650349223
-
Do predictive signatures really predict response to cancer chemotherapy?
-
Borst P, Wessels L,. Do predictive signatures really predict response to cancer chemotherapy? Cell Cycle 2010; 9: 4836-40.
-
(2010)
Cell Cycle
, vol.9
, pp. 4836-4840
-
-
Borst, P.1
Wessels, L.2
-
41
-
-
73149111923
-
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide
-
Bruheim S, Xi Y, Ju J, et al. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Clin Cancer Res 2009; 15: 7161-9.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 7161-7169
-
-
Bruheim, S.1
Xi, Y.2
Ju, J.3
-
42
-
-
7044226340
-
Human osteosarcoma xenografts and their sensitivity to chemotherapy
-
Bruheim S, Bruland OS, Breistol K, et al. Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res 2004; 10: 133-41.
-
(2004)
Pathol Oncol Res
, vol.10
, pp. 133-141
-
-
Bruheim, S.1
Bruland, O.S.2
Breistol, K.3
-
43
-
-
65549107328
-
Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling
-
Sadikovic B, Yoshimoto M, Chilton-MacNeill S, et al. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling. Hum Mol Genet 2009; 18: 1962-75.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 1962-1975
-
-
Sadikovic, B.1
Yoshimoto, M.2
Chilton-Macneill, S.3
-
44
-
-
84860662550
-
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
-
Kuijjer ML, Rydbeck H, Kresse SH, et al. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes Chromosomes Cancer 2012; 51: 696-706.
-
(2012)
Genes Chromosomes Cancer
, vol.51
, pp. 696-706
-
-
Kuijjer, M.L.1
Rydbeck, H.2
Kresse, S.H.3
-
45
-
-
65249167488
-
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
-
Kansara M, Tsang M, Kodjabachian L, et al. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J Clin Invest 2009; 119: 837-51.
-
(2009)
J Clin Invest
, vol.119
, pp. 837-851
-
-
Kansara, M.1
Tsang, M.2
Kodjabachian, L.3
-
46
-
-
84859386766
-
MiRNA signatures associate with pathogenesis and progression of osteosarcoma
-
Jones KB, Salah Z, Del MS, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865-77.
-
(2012)
Cancer Res
, vol.72
, pp. 1865-1877
-
-
Jones, K.B.1
Salah, Z.2
Del, M.S.3
-
47
-
-
84868110139
-
Modulation of the osteosarcoma expression phenotype by microRNAs
-
Namløs HM, Meza-Zepeda LA, Baroy T, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 2012; 7: e48086.
-
(2012)
PLoS One
, vol.7
-
-
Namløs, H.M.1
Meza-Zepeda, L.A.2
Baroy, T.3
-
48
-
-
77951791258
-
S-MED: Sarcoma microRNA expression database
-
Sarver AL, Phalak R, Thayanithy V, et al. S-MED: sarcoma microRNA expression database. Lab Invest 2010; 90: 753-61.
-
(2010)
Lab Invest
, vol.90
, pp. 753-761
-
-
Sarver, A.L.1
Phalak, R.2
Thayanithy, V.3
-
49
-
-
50949113230
-
In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma
-
Sadikovic B, Yoshimoto M, Al-Romaih K, et al. In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma. PLoS One 2008; 3: e2834.
-
(2008)
PLoS One
, vol.3
-
-
Sadikovic, B.1
Yoshimoto, M.2
Al-Romaih, K.3
-
50
-
-
84868128368
-
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma
-
Kresse SH, Rydbeck H, Skarn M, et al. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. PLoS One 2012; 7: e48262.
-
(2012)
PLoS One
, vol.7
-
-
Kresse, S.H.1
Rydbeck, H.2
Skarn, M.3
-
51
-
-
0141889935
-
High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays
-
Squire JA, Pei J, Marrano P, et al. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays. Genes Chromosomes Cancer 2003; 38: 215-25.
-
(2003)
Genes Chromosomes Cancer
, vol.38
, pp. 215-225
-
-
Squire, J.A.1
Pei, J.2
Marrano, P.3
-
52
-
-
13144300881
-
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
-
Man TK, Lu XY, Jaeweon K, et al. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Research Notes 2004; 7: 45.
-
(2004)
BMC Research Notes
, vol.7
, pp. 45
-
-
Man, T.K.1
Lu, X.Y.2
Jaeweon, K.3
-
53
-
-
19944427138
-
Gene amplifications in osteosarcoma-CGH microarray analysis
-
Atiye J, Wolf M, Kaur S, et al. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 2005; 42: 158-63.
-
(2005)
Genes Chromosomes Cancer
, vol.42
, pp. 158-163
-
-
Atiye, J.1
Wolf, M.2
Kaur, S.3
-
54
-
-
80053237717
-
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma
-
Yang J, Yang D, Sun Y, et al. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 2011; 117: 4925-38.
-
(2011)
Cancer
, vol.117
, pp. 4925-4938
-
-
Yang, J.1
Yang, D.2
Sun, Y.3
-
55
-
-
67650465624
-
LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
-
Kresse SH, Ohnstad HO, Paulsen EB, et al. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2009; 48: 679-93.
-
(2009)
Genes Chromosomes Cancer
, vol.48
, pp. 679-693
-
-
Kresse, S.H.1
Ohnstad, H.O.2
Paulsen, E.B.3
-
56
-
-
79954965424
-
Cyclin E1 is amplified and overexpressed in osteosarcoma
-
Lockwood WW, Stack D, Morris T, et al. Cyclin E1 is amplified and overexpressed in osteosarcoma. J Mol Diagn 2011; 13: 289-96.
-
(2011)
J Mol Diagn
, vol.13
, pp. 289-296
-
-
Lockwood, W.W.1
Stack, D.2
Morris, T.3
-
57
-
-
70449359177
-
Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma
-
Yen CC, Chen WM, Chen TH, et al. Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma. Int J Oncol 2009; 35: 775-88.
-
(2009)
Int J Oncol
, vol.35
, pp. 775-788
-
-
Yen, C.C.1
Chen, W.M.2
Chen, T.H.3
-
58
-
-
77956248437
-
Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours
-
Kresse SH, Szuhai K, Barragan-Polania AH, et al. Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. BMC Research Notes 2010; 3: 223.
-
(2010)
BMC Research Notes
, vol.3
, pp. 223
-
-
Kresse, S.H.1
Szuhai, K.2
Barragan-Polania, A.H.3
-
59
-
-
77955744323
-
Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma
-
Smida J, Baumhoer D, Rosemann M, et al. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res 2010; 16: 4256-67.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4256-4267
-
-
Smida, J.1
Baumhoer, D.2
Rosemann, M.3
-
60
-
-
75149191872
-
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma
-
Pasic I, Shlien A, Durbin AD, et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 2010; 70: 160-71.
-
(2010)
Cancer Res
, vol.70
, pp. 160-171
-
-
Pasic, I.1
Shlien, A.2
Durbin, A.D.3
-
61
-
-
1942530423
-
Conventional osteosarcoma, Genetics
-
Fletcher C.D.M. Unni K.K. Mertens F. eds. Lyon: IARC Press
-
Raymond AK, Ayala AG, Knuutila S,. Conventional osteosarcoma, Genetics. In:, Fletcher CDM, Unni KK, Mertens F, eds. World health classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002. 267-9.
-
(2002)
World Health Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
, pp. 267-269
-
-
Raymond, A.K.1
Ayala, A.G.2
Knuutila, S.3
-
62
-
-
0345714858
-
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
-
Lau CC, Harris CP, Lu XY, et al. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer 2004; 39: 11-21.
-
(2004)
Genes Chromosomes Cancer
, vol.39
, pp. 11-21
-
-
Lau, C.C.1
Harris, C.P.2
Lu, X.Y.3
-
63
-
-
41349122898
-
Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes
-
Lee H, Kong SW, Park PJ,. Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes. Bioinformatics 2008; 24: 889-96.
-
(2008)
Bioinformatics
, vol.24
, pp. 889-896
-
-
Lee, H.1
Kong, S.W.2
Park, P.J.3
-
64
-
-
84865378998
-
MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma
-
Baumhoer D, Zillmer S, Unger K, et al. MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet 2012; 205: 212-9.
-
(2012)
Cancer Genet
, vol.205
, pp. 212-219
-
-
Baumhoer, D.1
Zillmer, S.2
Unger, K.3
-
65
-
-
73649132981
-
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma
-
Cai Y, Mohseny AB, Karperien M, et al. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010; 220: 24-33.
-
(2010)
J Pathol
, vol.220
, pp. 24-33
-
-
Cai, Y.1
Mohseny, A.B.2
Karperien, M.3
-
66
-
-
36049042525
-
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway
-
Matushansky I, Hernando E, Socci ND, et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007; 117: 3248-57.
-
(2007)
J Clin Invest
, vol.117
, pp. 3248-3257
-
-
Matushansky, I.1
Hernando, E.2
Socci, N.D.3
-
67
-
-
79961020791
-
Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1
-
Malinauskas T, Aricescu AR, Lu W, et al. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 2011; 18: 886-93.
-
(2011)
Nat Struct Mol Biol
, vol.18
, pp. 886-893
-
-
Malinauskas, T.1
Aricescu, A.R.2
Lu, W.3
-
68
-
-
84861307078
-
Glycogen synthase kinase-3beta, NF-kappaB signaling, and tumorigenesis of human osteosarcoma
-
Tang QL, Xie XB, Wang J, et al. Glycogen synthase kinase-3beta, NF-kappaB signaling, and tumorigenesis of human osteosarcoma. J Natl Cancer Inst 2012; 104: 749-63.
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 749-763
-
-
Tang, Q.L.1
Xie, X.B.2
Wang, J.3
-
69
-
-
79955964176
-
High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A
-
Vijayakumar S, Liu G, Rus IA, et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell 2011; 19: 601-12.
-
(2011)
Cancer Cell
, vol.19
, pp. 601-612
-
-
Vijayakumar, S.1
Liu, G.2
Rus, I.A.3
-
70
-
-
84869488840
-
The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma
-
Mohseny AB, Cai Y, Kuijjer M, et al. The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma. Eur J Cancer 2012; 48: 3429-38.
-
(2012)
Eur J Cancer
, vol.48
, pp. 3429-3438
-
-
Mohseny, A.B.1
Cai, Y.2
Kuijjer, M.3
-
72
-
-
13344270394
-
Adjuvant therapy for osteosarcoma in dogs: Results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin
-
Kurzman ID, MacEwen EG, Rosenthal RC, et al. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1995; 1: 1595-601.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1595-1601
-
-
Kurzman, I.D.1
Macewen, E.G.2
Rosenthal, R.C.3
-
73
-
-
39149136228
-
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
-
Meyers PA, Schwartz CL, Krailo MD, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group. J Clin Oncol 2008; 26: 633-8.
-
(2008)
J Clin Oncol
, vol.26
, pp. 633-638
-
-
Meyers, P.A.1
Schwartz, C.L.2
Krailo, M.D.3
-
74
-
-
78650959663
-
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
-
Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.
-
(2011)
Cell
, vol.144
, pp. 27-40
-
-
Stephens, P.J.1
Greenman, C.D.2
Fu, B.3
-
75
-
-
78650539308
-
From RNA-seq reads to differential expression results
-
Oshlack A, Robinson MD, Young MD,. From RNA-seq reads to differential expression results. Genome Biol 2010; 11: 220.
-
(2010)
Genome Biol
, vol.11
, pp. 220
-
-
Oshlack, A.1
Robinson, M.D.2
Young, M.D.3
|